Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Th1 Dominant Nucleocapsid and Spike Antigen-Specific CD4+ and CD8+ Memory T Cell Recall Induced by hAd5 S-Fusion + N-ETSD Infection of Autologous Dendritic Cells from Patients Previously Infected with SARS-CoV-2

Peter Sieling, Lise Zakin, Annie Shin, Brett Morimoto, Helty Adisetiyo, Hermes Garban, Philip Liu, Adrian Rice, Justin Taft, Roosheel Patel, Sofija Buta, Marta Martin-Fernandez, View ORCID ProfileDusan Bogunovic, Elizabeth Gabitzsch, Jeffrey T. Safrit, Lennie Sender, Patricia Spilman, Shahrooz Rabizadeh, Kayvan Niazi, View ORCID ProfilePatrick Soon-Shiong
doi: https://doi.org/10.1101/2020.11.04.20225417
Peter Sieling
1ImmunityBio, Inc., 9920 Jefferson Blvd, Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lise Zakin
1ImmunityBio, Inc., 9920 Jefferson Blvd, Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annie Shin
1ImmunityBio, Inc., 9920 Jefferson Blvd, Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brett Morimoto
1ImmunityBio, Inc., 9920 Jefferson Blvd, Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helty Adisetiyo
1ImmunityBio, Inc., 9920 Jefferson Blvd, Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hermes Garban
1ImmunityBio, Inc., 9920 Jefferson Blvd, Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip Liu
1ImmunityBio, Inc., 9920 Jefferson Blvd, Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrian Rice
1ImmunityBio, Inc., 9920 Jefferson Blvd, Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Justin Taft
2Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029- 5674, USA SPA
3Department of Pediatrics, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029- 5674, USA SPA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roosheel Patel
2Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029- 5674, USA SPA
3Department of Pediatrics, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029- 5674, USA SPA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sofija Buta
2Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029- 5674, USA SPA
3Department of Pediatrics, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029- 5674, USA SPA
4Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029- 5674, USA SPA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marta Martin-Fernandez
2Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029- 5674, USA SPA
3Department of Pediatrics, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029- 5674, USA SPA
4Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029- 5674, USA SPA
5Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029- 5674, USA SPA
6Department of Microbiology, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029- 5674, USA SPA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dusan Bogunovic
2Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029- 5674, USA SPA
3Department of Pediatrics, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029- 5674, USA SPA
4Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029- 5674, USA SPA
5Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029- 5674, USA SPA
6Department of Microbiology, Icahn School of Medicine at Mount Sinai, 1 Gustave Lane, Levy Place, New York, NY 10029- 5674, USA SPA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dusan Bogunovic
Elizabeth Gabitzsch
1ImmunityBio, Inc., 9920 Jefferson Blvd, Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey T. Safrit
7NantKwest, Inc., 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lennie Sender
7NantKwest, Inc., 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia Spilman
1ImmunityBio, Inc., 9920 Jefferson Blvd, Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shahrooz Rabizadeh
1ImmunityBio, Inc., 9920 Jefferson Blvd, Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kayvan Niazi
1ImmunityBio, Inc., 9920 Jefferson Blvd, Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Soon-Shiong
1ImmunityBio, Inc., 9920 Jefferson Blvd, Culver City, CA 90232, USA
7NantKwest, Inc., 9920 Jefferson Blvd., Culver City, CA 90232, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patrick Soon-Shiong
  • For correspondence: Patrick@NantWorks.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

To address the need for a safe, efficacious vaccine against SARS-CoV-2 infection with the critical properties of enabling both blocking viral entry into cells and clearing virus from cells already infected, we have developed a bivalent, human adenovirus serotype 5 (hAd5) SARS-CoV- 2 S-Fusion + N-ETSD vaccine that is currently in clinical testing. This vaccine uses the next- generation hAd5 [E1-, E2b-, E3-] platform previously used successfully in cancer patients with pre-existing adenovirus immunity, engineered to express both SARS-CoV-2 spike (S) protein modified to improve the generation of neutralizing antibodies to block entry of the virus, and nucleocapsid (N) protein with an Enhanced T cell Stimulation Domain (ETSD) to activate CD4+ and CD8+ T cells to clear the virus and block replication by killing infected cells. The targeting of N to endosomes and lysosomes to enhance CD4+ and CD8+ T-cell responses distinguishes our vaccine. In our previously reported pre-clinical studies we showed that in mice, the hAd5 S-Fusion + N-ETSD vaccine elicits both humoral and T-cell responses that are robust and T helper cell 1 (Th1) dominant. Here we report that the hAd5 S-Fusion + N-ETSD vaccine is recognized by anti-sera and T cells from previously SARS-CoV-2 infected patients, and that the presence of N is vital for T-cell recall. The findings presented herein: (i) demonstrate specific recognition of hAd5 S-Fusion + N-ETSD infected cells by plasma antibodies from previously SARS-CoV-2 infected patients, but not antibodies from virus-naïve subjects; (ii) show enhanced binding of plasma SARS-CoV-2 antibodies from previously infected patients to monocyte-derived dendritic cells (MoDCs) expressing the hAd5 S-Fusion + N-ETSD vaccine as compared to hAd5 S-Fusion alone; (iii) reveal N-ETSD localizes to vesicles associated with MHC class II antigen presentation, including endosomes, lysosomes and autophagosomes in MoDCs; (iv) demonstrate endosome/lysosome-targeted N-ETSD elicits higher interferon-γ T-cell responses than cytoplasm-localized N; and (v) N-ETSD alone or in the hAd5 S-Fusion + N-ETSD construct induces both CD4+ and CD8+ T cell memory recall. This recognition of hAd5 S-Fusion + N-ETSD vaccine antigens by T cells from previously SARS-CoV-2 infected patients, together with the ability of this vaccine candidate to elicit de novo immune responses in naïve mice suggests that it re-capitulates the natural immune response to SARS-CoV-2 to activate both B and T cells towards viral neutralization and recognition of infected cells, critical for prevention of COVID-19 disease. Intriguingly, our hAd5 S-Fusion + N-ETSD T-cell biased vaccine has the potential to not only provide protection for uninfected individuals, but also to be utilized as a therapeutic for already infected patients to induce rapid clearance of the virus by activating T cells to kill the virus-infected cells, thereby reducing viral replication and lateral transmission.

Competing Interest Statement

The vaccine described has been developed by ImmunityBio LLC and NantKwest Inc. Most authors on the manuscript are employees or senior management of ImmunityBio LLC or NantKwest Inc.

Funding Statement

Study supported by ImmunityBio LLC and NantKwest Inc.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Advarra Study Subject Adviser Advarra IRB 6940 Columbia Gateway Drive, Suite 110 Columbia, MD 21046 877-992-4724 adviser{at}advarra.com Please reference the following number when contacting the Study Subject Advisor: Pro00044384.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All relevant data are presented in the manuscript

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted November 06, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Th1 Dominant Nucleocapsid and Spike Antigen-Specific CD4+ and CD8+ Memory T Cell Recall Induced by hAd5 S-Fusion + N-ETSD Infection of Autologous Dendritic Cells from Patients Previously Infected with SARS-CoV-2
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Th1 Dominant Nucleocapsid and Spike Antigen-Specific CD4+ and CD8+ Memory T Cell Recall Induced by hAd5 S-Fusion + N-ETSD Infection of Autologous Dendritic Cells from Patients Previously Infected with SARS-CoV-2
Peter Sieling, Lise Zakin, Annie Shin, Brett Morimoto, Helty Adisetiyo, Hermes Garban, Philip Liu, Adrian Rice, Justin Taft, Roosheel Patel, Sofija Buta, Marta Martin-Fernandez, Dusan Bogunovic, Elizabeth Gabitzsch, Jeffrey T. Safrit, Lennie Sender, Patricia Spilman, Shahrooz Rabizadeh, Kayvan Niazi, Patrick Soon-Shiong
medRxiv 2020.11.04.20225417; doi: https://doi.org/10.1101/2020.11.04.20225417
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Th1 Dominant Nucleocapsid and Spike Antigen-Specific CD4+ and CD8+ Memory T Cell Recall Induced by hAd5 S-Fusion + N-ETSD Infection of Autologous Dendritic Cells from Patients Previously Infected with SARS-CoV-2
Peter Sieling, Lise Zakin, Annie Shin, Brett Morimoto, Helty Adisetiyo, Hermes Garban, Philip Liu, Adrian Rice, Justin Taft, Roosheel Patel, Sofija Buta, Marta Martin-Fernandez, Dusan Bogunovic, Elizabeth Gabitzsch, Jeffrey T. Safrit, Lennie Sender, Patricia Spilman, Shahrooz Rabizadeh, Kayvan Niazi, Patrick Soon-Shiong
medRxiv 2020.11.04.20225417; doi: https://doi.org/10.1101/2020.11.04.20225417

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Allergy and Immunology
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (551)
  • Anesthesia (135)
  • Cardiovascular Medicine (1750)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (311)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (654)
  • Epidemiology (10790)
  • Forensic Medicine (8)
  • Gastroenterology (585)
  • Genetic and Genomic Medicine (2938)
  • Geriatric Medicine (286)
  • Health Economics (532)
  • Health Informatics (1920)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (291)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12503)
  • Intensive Care and Critical Care Medicine (686)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (324)
  • Neurology (2787)
  • Nursing (150)
  • Nutrition (432)
  • Obstetrics and Gynecology (556)
  • Occupational and Environmental Health (597)
  • Oncology (1458)
  • Ophthalmology (442)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (334)
  • Psychiatry and Clinical Psychology (2635)
  • Public and Global Health (5346)
  • Radiology and Imaging (1004)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (725)
  • Rheumatology (329)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)